Zolla-Pazner S - Search Results

1

Passive immunization for the prevention and treatment of HIV infection.

Zolla-Pazner S, Gorny MK. Zolla-Pazner S, et al. AIDS. 1992 Nov;6(11):1235-47. doi: 10.1097/00002030-199211000-00001. AIDS. 1992. PMID: 1472330 No abstract available.

2

Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D.

Stanfield RL, Gorny MK, Williams C, Zolla-Pazner S, Wilson IA. Stanfield RL, et al. Structure. 2004 Feb;12(2):193-204. doi: 10.1016/j.str.2004.01.003. Structure. 2004. PMID: 14962380 Free article.

3

Defining human immunodeficiency virus (HIV) type 1 immunotypes with six human monoclonal antibodies.

Nádas A, Zhong P, Burda S, Zekeng L, Urbanski M, Gorny MK, Zolla-Pazner S, Nyambi PN. Nádas A, et al. AIDS Res Hum Retroviruses. 2004 Jan;20(1):55-65. doi: 10.1089/088922204322749503. AIDS Res Hum Retroviruses. 2004. PMID: 15000699

4

Structural basis of the cross-reactivity of genetically related human anti-HIV-1 mAbs: implications for design of V3-based immunogens.

Burke V, Williams C, Sukumaran M, Kim SS, Li H, Wang XH, Gorny MK, Zolla-Pazner S, Kong XP. Burke V, et al. Structure. 2009 Nov 11;17(11):1538-46. doi: 10.1016/j.str.2009.09.012. Structure. 2009. PMID: 19913488 Free PMC article.

5

Structural analysis of human and macaque mAbs 2909 and 2.5B: implications for the configuration of the quaternary neutralizing epitope of HIV-1 gp120.

Spurrier B, Sampson JM, Totrov M, Li H, O'Neal T, Williams C, Robinson J, Gorny MK, Zolla-Pazner S, Kong XP. Spurrier B, et al. Structure. 2011 May 11;19(5):691-9. doi: 10.1016/j.str.2011.02.012. Structure. 2011. PMID: 21565703 Free PMC article.

6

Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function.

Chung AW, Crispin M, Pritchard L, Robinson H, Gorny MK, Yu X, Bailey-Kellogg C, Ackerman ME, Scanlan C, Zolla-Pazner S, Alter G. Chung AW, et al. AIDS. 2014 Nov 13;28(17):2523-30. doi: 10.1097/QAD.0000000000000444. AIDS. 2014. PMID: 25160934 Free PMC article.

7

A fully human antibody to gp41 selectively eliminates HIV-infected cells that transmigrated across a model human blood brain barrier.

McFarren A, Lopez L, Williams DW, Veenstra M, Bryan RA, Goldsmith A, Morgenstern A, Bruchertseifer F, Zolla-Pazner S, Gorny MK, Eugenin EA, Berman JW, Dadachova E. McFarren A, et al. AIDS. 2016 Feb 20;30(4):563-72. doi: 10.1097/QAD.0000000000000968. AIDS. 2016. PMID: 26595540 Free PMC article.

8

Production of human monoclonal antibodies specific for conformational and linear non-V3 epitopes of gp120.

Karwowska S, Gorny MK, Buchbinder A, Gianakakos V, Williams C, Fuerst T, Zolla-Pazner S. Karwowska S, et al. AIDS Res Hum Retroviruses. 1992 Jun;8(6):1099-106. doi: 10.1089/aid.1992.8.1099. AIDS Res Hum Retroviruses. 1992. PMID: 1380257

9

Synergy between human monoclonal antibodies to HIV extends their effective biologic activity against homologous and divergent strains.

Buchbinder A, Zolla-Pazner S, Karwowska S, Gorny MK, Burda ST. Buchbinder A, et al. AIDS Res Hum Retroviruses. 1992 Aug;8(8):1395. doi: 10.1089/aid.1992.8.1395. AIDS Res Hum Retroviruses. 1992. PMID: 1466965 No abstract available.

10

Synergy between human monoclonal antibodies to HIV extends their effective biologic activity against homologous and divergent strains.

Buchbinder A, Karwowska S, Gorny MK, Burda ST, Zolla-Pazner S. Buchbinder A, et al. AIDS Res Hum Retroviruses. 1992 Apr;8(4):425-7. doi: 10.1089/aid.1992.8.425. AIDS Res Hum Retroviruses. 1992. PMID: 1599752 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters